Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
my interpretation is Clay Trader says buy Clvs!! I agree with Clay
Bought more shares 62.5% short interest rate ouch!
Md yep I imagine a $3 billion MC with remission of another person in ongoing pancreatic cancer trial!
Interest rate now 57% to short this.
Micro I don’t disagree with you . I have wondered the same thing too. Why doesn’t a Baker Brothers do that? I don’t actually know why. Can’t give you a good answer on that
They already stated they aren't the corona company!!!
Micro, I don't know those rules. However, all I know is our MultiTaa treatment works for lymphoma, pancreatic cancer , AML and I would imagine sarcoma, and breast cancer. The only reason Mrkr is not at least $10 right now is due to the 5 million shares shorted by large hedge funds
Joy Patient #12 in pancreatic trial could be the 2nd person in complete remission. He or she was going to receive 3 more MutliTaa treatments at the end of 2019 and in January and February 2020. 40% of the tumor has been dissolved by the 1st three months of MultiTAA treatment. The company already knows what the results are and will be sharing this information in the 3rd quarter this year. They have been adding staff so I take that they know they can get additional funding and have the goods. I am hopeful for a partnership with someone like Merck where they pay for additional trials for pancreatic cancer and we give them a percentage of future revenue.
Why new investors are lucky to buy this stock at these prices! They might have tripped into our company but if we put a second person in complete remission for pancreatic cancer during our Current phase I trial we can easily go up to $90 a share or $4 billion market cap. FYI just so you newbies know we are not the marker with a Coronavirus product. We are an immunotherapy company that has 8 or so phase i trials for multiple cancer indications. FYI we have blown up solid tumors for pancreatic cancer and the person is 18 in complete remission. Our MutiTaa works
Thanks Pancreatic cancer remission on our 1 patient and hopefully 2 when they release results in 3rd quarter is what we have to live with and our phase 2 on AML.
Who knows are company should confirm or let people know if this is ours or not and some guidance
Now the interest rate is 50%!
Fidelity charging 44.75% now! Hoping 80% is in the cards in the not so distant future.
Jnc I think that is a good sign! I could be wrong about my assessment on AT but logical steps with us having blown up tumor cells and he said last year that 40% of his tumors have shrunk and we shown that tumor have shrunk in other patients last July my mind jumps to him being in our trial. I don’t throw cold water on our company like others. I have a significant stake in this and I do extensive research. If I only had a few hundred shares I wouldn’t do all my research about small biotechs. One doesn’t need to travel to Houston to be in our trial we just need their blood sample. Also, we know that Md Anderson is the leader in cancer research and Baylor is their sister campus.We wouldn’t be adding more staff unless we know we have significant funding forthcoming. I will speculate that we will have some sort of partnership with big pharma in the not so distance future. This whole investment in Marker is totally speculative since we have no revenue. Anyone that owns shares is speculating that we own the treatments or why do they own shares? They are speculating aren’t they? They made these leap with their money but don’t want me to speculate.
Fidelity charging 41.5% higher it goes! Hoping that it gets up to 80% soon for the short interest players!
Buck please identify which other companies and trials that are currnetly have a phase I or 2 trials ongoing other than marker for pancreatic cancer that you are refencing so we all can research and do our due diligence? Please share
Alex Trbek is getting immunotherapy treatment confirmed! I found a YouTube video with Th National which is a Canadian news show over in Canada. At about the 6 minute mark Alex himself stares he is getting immunotherapy treatment. I would post the video but I am technology challenged. I was wondering how he as still alive an now we have the answer. The video on YouTube is 10 months old! I would think Marker is treating Alex. Somebody better at adding links can post the video to confirm my statements.
Fidelity charging 37.25% to short Clvs now! Need this rate up to 80% within next week.
Sean my educated guess is $25 aa share since they have debt that you would have to factor in a potential buyout too. I am not an expert in this stock like I am in marker Therapeutics. But I think the risk reward is compelling right now. Downside worst case scenario is down 2 share and upside is 18 or so so a 9 to 1 ratio. In my mind hence my chips are in. Lol
Sup I own clvs and Mrkr! These shorts like clay trader can hammer these stocks down for a long time then they explode one day. Look at Axsm, mrtx, and kodiak’s 5 year charts. Their game is to short these stocks into oblivion with Fidelity’s help with their lending program. They all of a sudden the stock goes up like a rocket ship. I bought clvs at $9 a couple of months ago. I am wise to the game now. I bought clvs once I heard that the fda will either approve their prostrate drug by May so I don’t have long to wait.
Fidelity is helping to destroy their own golden goose! Equites are down about $11 trillion. Fidelity has a very large managed 401k business for large corporations that have helped destroy companies like Mrkr and others. Their managed fees will be down 35% if they don't get 401k balances up by the time they charge their 1% at the end of the month. Therefore I read an article this week that they are starting to increase the interest they charge the hedge funds that short. I read one traders daily interest has changed from $3 million a day to $4.5 million a day of interest. I would anticipate they further increase the rates to get these hedge funds to cover. It is in fidelity's financial interest. . We shall see if this applies to Mrkr. Raymond James does not get involved in this lending practice. Not sure of other brokerage houses
Stay safe micro and all. I believe we are forming a nice base from which to rocket up from when the time comes with updates or a pancreatic partnership with big pharma or a deal with the baker brothers like Kodiak. Our time will come
Is our company worth only $23 million for 9 years of studies after you strip out our cash?I think not and will not sell. Our price has been destroyed like 40% on trading of less than 2 million shares the last week. I ain’t selling. Can’t take my shares
A hole $250,000 of trading in Marker today! What does that tell you Tom?
Really Tom? Are we at $2
Invest On their website you can listen to Peter’s presentation at Boston Mass. very informative speech.
Takeaways from 3/4 presentation:Only $20 million or less from AML phase 2 trial.imo this is extremely cheap for this 160 people trial acceding to Peter. Our pancreatic PFF is 13 months which is 7 months longer than the current chemo PFF of 6 months. Lymphoma results are excellent too. IMO we will get approval for the three treatments.
Now we can do deal on pancreatic cancer trial! I am sure we can do a big pharma deal for a % of future revenue for pancreatic cancer. They fund future trials and we give up revenue. We stay public and we are inoculated with all these hedge funds owning our company. Love the deal today. After we announce pancreatic trial deal our share price goes up and then we start issuing these shares as we see fit
IMO Great deal! Since our trial for Aml didn’t start this year we already have cash until May of 2021. Now we have cash probrably thru December 2022. We shall see how close I am when they release this information.
Lol it does mean nothing!! Sorry tom
Thanks
Phantom I thought public companies had to provide a quarterly financial update every quarter? Did they ever announce a earnings update for 4th quarter? Thanks
Thanks
Silver lining with perceptive selling their shares could be less dilution since I would imagine they probably have no more warrants at $5 since they sold their shares. If pancreatic cancer results are outstanding and we get a partnership it would be good for us if their don't have their warrants now.
FYI shorts never get out look at a 5 year chart of Asxm and MRTX. They drive the price of these biotechs down they buy calls and shares when it goes from 5 to 100 a share.
Those percentages are typical from what I understand.
Perspective is disappointing but they probably got frustrated that management didn’t hit their milestones.
13f's out Blacrock increases stake to 1,982,000 shares up 5.2 %. . Looks like a few new investment firms took new stakes at over than 100,000'share. Overall, it appears institutions have increased their stake in Marker thru December 31,2019. These results are for th quarter before our hold is lifted.
Micro, Our current cash will last until June 2021. My projection will be very close when they update us since we are not spending hardly any of the $35 million or so this year. With the trial delay our capital raise will be pushed too. We won’t need to raise money until October of this year. Just watch. I used to work n these sorts of things in my work life. I know numbers and will be right just wait.